Clinical Trial Update: Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of a glargine-based discharge algorithm in patients undergoing CABG with poor glycemic control; results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Poor Glycemic Control in Diabetes

Drugs mentioned

• glargine-based discharge algorithm (insulin glargine)

Snippet

Sponsor: Emory University | Conditions: Poor Glycemic Control | Phase 3 | Status: COMPLETED | Results posted: 2015-10-29